Global Oral COVID-19 Vaccine Market Growth 2026-2032
The global Oral COVID-19 Vaccine market size is predicted to grow from US$ 955 million in 2025 to US$ 1379 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Oral COVID-19 Vaccine Industry Forecast? looks at past sales and reviews total world Oral COVID-19 Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral COVID-19 Vaccine sales for 2026 through 2032. With Oral COVID-19 Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral COVID-19 Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Oral COVID-19 Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral COVID-19 Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oral COVID-19 Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral COVID-19 Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral COVID-19 Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral COVID-19 Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Oral COVID-19 Vaccine Industry Forecast? looks at past sales and reviews total world Oral COVID-19 Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral COVID-19 Vaccine sales for 2026 through 2032. With Oral COVID-19 Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral COVID-19 Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Oral COVID-19 Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral COVID-19 Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oral COVID-19 Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral COVID-19 Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral COVID-19 Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral COVID-19 Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tablet Type
- Inhalable Type
- Adults
- Children
- Elderly
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- CanSino Biologics
- Kindred Biosciences, Inc.
- Zhejiang Huahai Pharmaceutical Co.,ltd.
- Shandong Xinhua Pharmaceutical
- Kintor Pharmaceutical
- Henan Genuine Biotech Co., Ltd.
- What is the 10-year outlook for the global Oral COVID-19 Vaccine market?
- What factors are driving Oral COVID-19 Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Oral COVID-19 Vaccine market opportunities vary by end market size?
- How does Oral COVID-19 Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral COVID-19 Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oral COVID-19 Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oral COVID-19 Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Oral COVID-19 Vaccine Segment by Type
2.2.1 Tablet Type
2.2.2 Inhalable Type
2.2.3 Oral COVID-19 Vaccine Sales by Type
2.2.3.1 Global Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Oral COVID-19 Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Oral COVID-19 Vaccine Sale Price by Type (2021-2026)
2.3 Oral COVID-19 Vaccine Segment by Application
2.3.1 Adults
2.3.2 Children
2.3.3 Elderly
2.3.4 Oral COVID-19 Vaccine Sales by Application
2.3.4.1 Global Oral COVID-19 Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Oral COVID-19 Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Oral COVID-19 Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oral COVID-19 Vaccine Breakdown Data by Company
3.1.1 Global Oral COVID-19 Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Oral COVID-19 Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Oral COVID-19 Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Oral COVID-19 Vaccine Revenue by Company (2021-2026)
3.2.2 Global Oral COVID-19 Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Oral COVID-19 Vaccine Sale Price by Company
3.4 Key Manufacturers Oral COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral COVID-19 Vaccine Product Location Distribution
3.4.2 Players Oral COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL COVID-19 VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Oral COVID-19 Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Oral COVID-19 Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oral COVID-19 Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oral COVID-19 Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Oral COVID-19 Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oral COVID-19 Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral COVID-19 Vaccine Sales Growth
4.4 APAC Oral COVID-19 Vaccine Sales Growth
4.5 Europe Oral COVID-19 Vaccine Sales Growth
4.6 Middle East & Africa Oral COVID-19 Vaccine Sales Growth
5 AMERICAS
5.1 Americas Oral COVID-19 Vaccine Sales by Country
5.1.1 Americas Oral COVID-19 Vaccine Sales by Country (2021-2026)
5.1.2 Americas Oral COVID-19 Vaccine Revenue by Country (2021-2026)
5.2 Americas Oral COVID-19 Vaccine Sales by Type (2021-2026)
5.3 Americas Oral COVID-19 Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral COVID-19 Vaccine Sales by Region
6.1.1 APAC Oral COVID-19 Vaccine Sales by Region (2021-2026)
6.1.2 APAC Oral COVID-19 Vaccine Revenue by Region (2021-2026)
6.2 APAC Oral COVID-19 Vaccine Sales by Type (2021-2026)
6.3 APAC Oral COVID-19 Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral COVID-19 Vaccine by Country
7.1.1 Europe Oral COVID-19 Vaccine Sales by Country (2021-2026)
7.1.2 Europe Oral COVID-19 Vaccine Revenue by Country (2021-2026)
7.2 Europe Oral COVID-19 Vaccine Sales by Type (2021-2026)
7.3 Europe Oral COVID-19 Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral COVID-19 Vaccine by Country
8.1.1 Middle East & Africa Oral COVID-19 Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oral COVID-19 Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Oral COVID-19 Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Oral COVID-19 Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral COVID-19 Vaccine
10.3 Manufacturing Process Analysis of Oral COVID-19 Vaccine
10.4 Industry Chain Structure of Oral COVID-19 Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral COVID-19 Vaccine Distributors
11.3 Oral COVID-19 Vaccine Customer
12 WORLD FORECAST REVIEW FOR ORAL COVID-19 VACCINE BY GEOGRAPHIC REGION
12.1 Global Oral COVID-19 Vaccine Market Size Forecast by Region
12.1.1 Global Oral COVID-19 Vaccine Forecast by Region (2027-2032)
12.1.2 Global Oral COVID-19 Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oral COVID-19 Vaccine Forecast by Type (2027-2032)
12.7 Global Oral COVID-19 Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Oral COVID-19 Vaccine Product Portfolios and Specifications
13.1.3 Pfizer Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 CanSino Biologics
13.2.1 CanSino Biologics Company Information
13.2.2 CanSino Biologics Oral COVID-19 Vaccine Product Portfolios and Specifications
13.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CanSino Biologics Main Business Overview
13.2.5 CanSino Biologics Latest Developments
13.3 Kindred Biosciences, Inc.
13.3.1 Kindred Biosciences, Inc. Company Information
13.3.2 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolios and Specifications
13.3.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Kindred Biosciences, Inc. Main Business Overview
13.3.5 Kindred Biosciences, Inc. Latest Developments
13.4 Zhejiang Huahai Pharmaceutical Co.,ltd.
13.4.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
13.4.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
13.4.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Main Business Overview
13.4.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Latest Developments
13.5 Shandong Xinhua Pharmaceutical
13.5.1 Shandong Xinhua Pharmaceutical Company Information
13.5.2 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
13.5.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Shandong Xinhua Pharmaceutical Main Business Overview
13.5.5 Shandong Xinhua Pharmaceutical Latest Developments
13.6 Kintor Pharmaceutical
13.6.1 Kintor Pharmaceutical Company Information
13.6.2 Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
13.6.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kintor Pharmaceutical Main Business Overview
13.6.5 Kintor Pharmaceutical Latest Developments
13.7 Henan Genuine Biotech Co., Ltd.
13.7.1 Henan Genuine Biotech Co., Ltd. Company Information
13.7.2 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
13.7.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Henan Genuine Biotech Co., Ltd. Main Business Overview
13.7.5 Henan Genuine Biotech Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral COVID-19 Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oral COVID-19 Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oral COVID-19 Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Oral COVID-19 Vaccine Segment by Type
2.2.1 Tablet Type
2.2.2 Inhalable Type
2.2.3 Oral COVID-19 Vaccine Sales by Type
2.2.3.1 Global Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Oral COVID-19 Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Oral COVID-19 Vaccine Sale Price by Type (2021-2026)
2.3 Oral COVID-19 Vaccine Segment by Application
2.3.1 Adults
2.3.2 Children
2.3.3 Elderly
2.3.4 Oral COVID-19 Vaccine Sales by Application
2.3.4.1 Global Oral COVID-19 Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Oral COVID-19 Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Oral COVID-19 Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oral COVID-19 Vaccine Breakdown Data by Company
3.1.1 Global Oral COVID-19 Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Oral COVID-19 Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Oral COVID-19 Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Oral COVID-19 Vaccine Revenue by Company (2021-2026)
3.2.2 Global Oral COVID-19 Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Oral COVID-19 Vaccine Sale Price by Company
3.4 Key Manufacturers Oral COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral COVID-19 Vaccine Product Location Distribution
3.4.2 Players Oral COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL COVID-19 VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Oral COVID-19 Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Oral COVID-19 Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oral COVID-19 Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oral COVID-19 Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Oral COVID-19 Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oral COVID-19 Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral COVID-19 Vaccine Sales Growth
4.4 APAC Oral COVID-19 Vaccine Sales Growth
4.5 Europe Oral COVID-19 Vaccine Sales Growth
4.6 Middle East & Africa Oral COVID-19 Vaccine Sales Growth
5 AMERICAS
5.1 Americas Oral COVID-19 Vaccine Sales by Country
5.1.1 Americas Oral COVID-19 Vaccine Sales by Country (2021-2026)
5.1.2 Americas Oral COVID-19 Vaccine Revenue by Country (2021-2026)
5.2 Americas Oral COVID-19 Vaccine Sales by Type (2021-2026)
5.3 Americas Oral COVID-19 Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral COVID-19 Vaccine Sales by Region
6.1.1 APAC Oral COVID-19 Vaccine Sales by Region (2021-2026)
6.1.2 APAC Oral COVID-19 Vaccine Revenue by Region (2021-2026)
6.2 APAC Oral COVID-19 Vaccine Sales by Type (2021-2026)
6.3 APAC Oral COVID-19 Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral COVID-19 Vaccine by Country
7.1.1 Europe Oral COVID-19 Vaccine Sales by Country (2021-2026)
7.1.2 Europe Oral COVID-19 Vaccine Revenue by Country (2021-2026)
7.2 Europe Oral COVID-19 Vaccine Sales by Type (2021-2026)
7.3 Europe Oral COVID-19 Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral COVID-19 Vaccine by Country
8.1.1 Middle East & Africa Oral COVID-19 Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oral COVID-19 Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Oral COVID-19 Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Oral COVID-19 Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral COVID-19 Vaccine
10.3 Manufacturing Process Analysis of Oral COVID-19 Vaccine
10.4 Industry Chain Structure of Oral COVID-19 Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral COVID-19 Vaccine Distributors
11.3 Oral COVID-19 Vaccine Customer
12 WORLD FORECAST REVIEW FOR ORAL COVID-19 VACCINE BY GEOGRAPHIC REGION
12.1 Global Oral COVID-19 Vaccine Market Size Forecast by Region
12.1.1 Global Oral COVID-19 Vaccine Forecast by Region (2027-2032)
12.1.2 Global Oral COVID-19 Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oral COVID-19 Vaccine Forecast by Type (2027-2032)
12.7 Global Oral COVID-19 Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Oral COVID-19 Vaccine Product Portfolios and Specifications
13.1.3 Pfizer Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 CanSino Biologics
13.2.1 CanSino Biologics Company Information
13.2.2 CanSino Biologics Oral COVID-19 Vaccine Product Portfolios and Specifications
13.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CanSino Biologics Main Business Overview
13.2.5 CanSino Biologics Latest Developments
13.3 Kindred Biosciences, Inc.
13.3.1 Kindred Biosciences, Inc. Company Information
13.3.2 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolios and Specifications
13.3.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Kindred Biosciences, Inc. Main Business Overview
13.3.5 Kindred Biosciences, Inc. Latest Developments
13.4 Zhejiang Huahai Pharmaceutical Co.,ltd.
13.4.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
13.4.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
13.4.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Main Business Overview
13.4.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Latest Developments
13.5 Shandong Xinhua Pharmaceutical
13.5.1 Shandong Xinhua Pharmaceutical Company Information
13.5.2 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
13.5.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Shandong Xinhua Pharmaceutical Main Business Overview
13.5.5 Shandong Xinhua Pharmaceutical Latest Developments
13.6 Kintor Pharmaceutical
13.6.1 Kintor Pharmaceutical Company Information
13.6.2 Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
13.6.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kintor Pharmaceutical Main Business Overview
13.6.5 Kintor Pharmaceutical Latest Developments
13.7 Henan Genuine Biotech Co., Ltd.
13.7.1 Henan Genuine Biotech Co., Ltd. Company Information
13.7.2 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
13.7.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Henan Genuine Biotech Co., Ltd. Main Business Overview
13.7.5 Henan Genuine Biotech Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral COVID-19 Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oral COVID-19 Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players ofTablet Type
Table 4. Major Players of Inhalable Type
Table 5. Global Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Oral COVID-19 Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Oral COVID-19 Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Oral COVID-19 Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Oral COVID-19 Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Oral COVID-19 Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Oral COVID-19 Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Oral COVID-19 Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Oral COVID-19 Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Oral COVID-19 Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Oral COVID-19 Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Oral COVID-19 Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Oral COVID-19 Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Oral COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 21. Players Oral COVID-19 Vaccine Products Offered
Table 22. Oral COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oral COVID-19 Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Oral COVID-19 Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Oral COVID-19 Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Oral COVID-19 Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Oral COVID-19 Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Oral COVID-19 Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Oral COVID-19 Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Oral COVID-19 Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Oral COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Oral COVID-19 Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Oral COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Oral COVID-19 Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Oral COVID-19 Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Oral COVID-19 Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Oral COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Oral COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Oral COVID-19 Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Oral COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Oral COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Oral COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Oral COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Oral COVID-19 Vaccine
Table 52. Key Market Challenges & Risks of Oral COVID-19 Vaccine
Table 53. Key Industry Trends of Oral COVID-19 Vaccine
Table 54. Oral COVID-19 Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oral COVID-19 Vaccine Distributors List
Table 57. Oral COVID-19 Vaccine Customer List
Table 58. Global Oral COVID-19 Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Oral COVID-19 Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Oral COVID-19 Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Oral COVID-19 Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Oral COVID-19 Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Oral COVID-19 Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Oral COVID-19 Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Oral COVID-19 Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Oral COVID-19 Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Oral COVID-19 Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Oral COVID-19 Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Pfizer Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 74. Pfizer Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. CanSino Biologics Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. CanSino Biologics Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 79. CanSino Biologics Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CanSino Biologics Main Business
Table 81. CanSino Biologics Latest Developments
Table 82. Kindred Biosciences, Inc. Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 84. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Kindred Biosciences, Inc. Main Business
Table 86. Kindred Biosciences, Inc. Latest Developments
Table 87. Zhejiang Huahai Pharmaceutical Co.,ltd. Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 89. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Zhejiang Huahai Pharmaceutical Co.,ltd. Main Business
Table 91. Zhejiang Huahai Pharmaceutical Co.,ltd. Latest Developments
Table 92. Shandong Xinhua Pharmaceutical Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 94. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Shandong Xinhua Pharmaceutical Main Business
Table 96. Shandong Xinhua Pharmaceutical Latest Developments
Table 97. Kintor Pharmaceutical Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 99. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Kintor Pharmaceutical Main Business
Table 101. Kintor Pharmaceutical Latest Developments
Table 102. Henan Genuine Biotech Co., Ltd. Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 104. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Henan Genuine Biotech Co., Ltd. Main Business
Table 106. Henan Genuine Biotech Co., Ltd. Latest Developments
Table 1. Oral COVID-19 Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oral COVID-19 Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players ofTablet Type
Table 4. Major Players of Inhalable Type
Table 5. Global Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Oral COVID-19 Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Oral COVID-19 Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Oral COVID-19 Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Oral COVID-19 Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Oral COVID-19 Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Oral COVID-19 Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Oral COVID-19 Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Oral COVID-19 Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Oral COVID-19 Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Oral COVID-19 Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Oral COVID-19 Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Oral COVID-19 Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Oral COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 21. Players Oral COVID-19 Vaccine Products Offered
Table 22. Oral COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oral COVID-19 Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Oral COVID-19 Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Oral COVID-19 Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Oral COVID-19 Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Oral COVID-19 Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Oral COVID-19 Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Oral COVID-19 Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Oral COVID-19 Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Oral COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Oral COVID-19 Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Oral COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Oral COVID-19 Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Oral COVID-19 Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Oral COVID-19 Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Oral COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Oral COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Oral COVID-19 Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Oral COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Oral COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Oral COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Oral COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Oral COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Oral COVID-19 Vaccine
Table 52. Key Market Challenges & Risks of Oral COVID-19 Vaccine
Table 53. Key Industry Trends of Oral COVID-19 Vaccine
Table 54. Oral COVID-19 Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oral COVID-19 Vaccine Distributors List
Table 57. Oral COVID-19 Vaccine Customer List
Table 58. Global Oral COVID-19 Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Oral COVID-19 Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Oral COVID-19 Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Oral COVID-19 Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Oral COVID-19 Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Oral COVID-19 Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Oral COVID-19 Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Oral COVID-19 Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Oral COVID-19 Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Oral COVID-19 Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Oral COVID-19 Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Pfizer Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 74. Pfizer Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. CanSino Biologics Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. CanSino Biologics Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 79. CanSino Biologics Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CanSino Biologics Main Business
Table 81. CanSino Biologics Latest Developments
Table 82. Kindred Biosciences, Inc. Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 84. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Kindred Biosciences, Inc. Main Business
Table 86. Kindred Biosciences, Inc. Latest Developments
Table 87. Zhejiang Huahai Pharmaceutical Co.,ltd. Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 89. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Zhejiang Huahai Pharmaceutical Co.,ltd. Main Business
Table 91. Zhejiang Huahai Pharmaceutical Co.,ltd. Latest Developments
Table 92. Shandong Xinhua Pharmaceutical Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 94. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Shandong Xinhua Pharmaceutical Main Business
Table 96. Shandong Xinhua Pharmaceutical Latest Developments
Table 97. Kintor Pharmaceutical Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 99. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Kintor Pharmaceutical Main Business
Table 101. Kintor Pharmaceutical Latest Developments
Table 102. Henan Genuine Biotech Co., Ltd. Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 104. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Henan Genuine Biotech Co., Ltd. Main Business
Table 106. Henan Genuine Biotech Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral COVID-19 Vaccine
Figure 2. Oral COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral COVID-19 Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oral COVID-19 Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oral COVID-19 Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oral COVID-19 Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Oral COVID-19 Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture ofTablet Type
Figure 12. Product Picture of Inhalable Type
Figure 13. Global Oral COVID-19 Vaccine Sales Market Share by Type in 2026
Figure 14. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Oral COVID-19 Vaccine Consumed in Adults
Figure 16. Global Oral COVID-19 Vaccine Market: Adults (2021-2026) & (K Units)
Figure 17. Oral COVID-19 Vaccine Consumed in Children
Figure 18. Global Oral COVID-19 Vaccine Market: Children (2021-2026) & (K Units)
Figure 19. Oral COVID-19 Vaccine Consumed in Elderly
Figure 20. Global Oral COVID-19 Vaccine Market: Elderly (2021-2026) & (K Units)
Figure 21. Global Oral COVID-19 Vaccine Sale Market Share by Application (2025)
Figure 22. Global Oral COVID-19 Vaccine Revenue Market Share by Application in 2026
Figure 23. Oral COVID-19 Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global Oral COVID-19 Vaccine Sales Market Share by Company in 2026
Figure 25. Oral COVID-19 Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global Oral COVID-19 Vaccine Revenue Market Share by Company in 2026
Figure 27. Global Oral COVID-19 Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Oral COVID-19 Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Oral COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas Oral COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC Oral COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC Oral COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe Oral COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe Oral COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Oral COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Oral COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas Oral COVID-19 Vaccine Sales Market Share by Country in 2026
Figure 38. Americas Oral COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas Oral COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Oral COVID-19 Vaccine Sales Market Share by Region in 2026
Figure 46. APAC Oral COVID-19 Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC Oral COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Oral COVID-19 Vaccine Sales Market Share by Country in 2026
Figure 57. Europe Oral COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe Oral COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Oral COVID-19 Vaccine in 2026
Figure 74. Manufacturing Process Analysis of Oral COVID-19 Vaccine
Figure 75. Industry Chain Structure of Oral COVID-19 Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Oral COVID-19 Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Oral COVID-19 Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Oral COVID-19 Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Oral COVID-19 Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Oral COVID-19 Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Oral COVID-19 Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Oral COVID-19 Vaccine
Figure 2. Oral COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral COVID-19 Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oral COVID-19 Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oral COVID-19 Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oral COVID-19 Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Oral COVID-19 Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture ofTablet Type
Figure 12. Product Picture of Inhalable Type
Figure 13. Global Oral COVID-19 Vaccine Sales Market Share by Type in 2026
Figure 14. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Oral COVID-19 Vaccine Consumed in Adults
Figure 16. Global Oral COVID-19 Vaccine Market: Adults (2021-2026) & (K Units)
Figure 17. Oral COVID-19 Vaccine Consumed in Children
Figure 18. Global Oral COVID-19 Vaccine Market: Children (2021-2026) & (K Units)
Figure 19. Oral COVID-19 Vaccine Consumed in Elderly
Figure 20. Global Oral COVID-19 Vaccine Market: Elderly (2021-2026) & (K Units)
Figure 21. Global Oral COVID-19 Vaccine Sale Market Share by Application (2025)
Figure 22. Global Oral COVID-19 Vaccine Revenue Market Share by Application in 2026
Figure 23. Oral COVID-19 Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global Oral COVID-19 Vaccine Sales Market Share by Company in 2026
Figure 25. Oral COVID-19 Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global Oral COVID-19 Vaccine Revenue Market Share by Company in 2026
Figure 27. Global Oral COVID-19 Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Oral COVID-19 Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Oral COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas Oral COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC Oral COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC Oral COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe Oral COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe Oral COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Oral COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Oral COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas Oral COVID-19 Vaccine Sales Market Share by Country in 2026
Figure 38. Americas Oral COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas Oral COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Oral COVID-19 Vaccine Sales Market Share by Region in 2026
Figure 46. APAC Oral COVID-19 Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC Oral COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Oral COVID-19 Vaccine Sales Market Share by Country in 2026
Figure 57. Europe Oral COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe Oral COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Oral COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Oral COVID-19 Vaccine in 2026
Figure 74. Manufacturing Process Analysis of Oral COVID-19 Vaccine
Figure 75. Industry Chain Structure of Oral COVID-19 Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Oral COVID-19 Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Oral COVID-19 Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Oral COVID-19 Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Oral COVID-19 Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Oral COVID-19 Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Oral COVID-19 Vaccine Revenue Market Share Forecast by Application (2027-2032)
